Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma
- PMID: 21710097
- PMCID: PMC4223790
- DOI: 10.1590/s1678-77572011005000013
Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma
Abstract
The Human Papillomavirus (HPV) has been strongly implicated in development of some cases of oral squamous cell carcinoma (OSCC). However, the immunological system somehow reacts against the presence of this virus. Among the cells involved in such mechanism of defense Langerhans cells (LC) stand out, which are responsible for processing and presenting antigens.
Objectives: The purposes of this study were to investigate the presence of HPV DNA and to evaluate the immunohistochemical reactivity for Langerhans cells between HPV-positive and HPV-negative OSCC. Twenty-seven cases of OSSC were evaluated.
Material and methods: DNA was extracted from paraffin-embedded tissue samples and amplified by Polymerase Chain Reaction (PCR) for the detection of HPV DNA. Viral typing was performed by dot blot hybridization. Immunohistochemistry was performed by the Streptavidin-biotin technique.
Results: From the 27 cases, 9 (33.3%) were HPV-positive and 18 (66.0%) HPV-negative. HPV 18 was the most prevalent viral type (100% cases) and infection with HPV-16 (co-infection) was detected in only 1 case. In the OSCC specimens examined, immunoreactivity to S-100 antibody was detected in all cases, with a mean number of 49.48±30.89 Langerhans cells positive for immunostaining. The mean number of immunostained Langerhans cells was smaller in the HPV-positive cases (38 cells/case) than in the HPV-negative cases (42.5 cells/case), but this difference was not significant (p=0.38).
Conclusions: The low frequency of detection of HPV DNA in OSCC indicates a possible participation of the virus in the development and progression of only a subgroup of these tumors. There was no association between the immunohistochemical labeling for Langerhans cells (S-100+) and HPV infection of in OSSC. These findings suggest that the presence of HPV in such OSCC cases could not alter the immunological system, particularly the Langerhans cells.
Figures



Similar articles
-
Detection of HPV DNA and immunohistochemical expression of cell cycle proteins in oral carcinoma in a population of Brazilian patients.J Appl Oral Sci. 2008 Sep-Oct;16(5):340-4. doi: 10.1590/s1678-77572008000500007. J Appl Oral Sci. 2008. PMID: 19089231 Free PMC article.
-
Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.J Oral Pathol Med. 2016 Sep;45(8):565-72. doi: 10.1111/jop.12416. Epub 2015 Dec 29. J Oral Pathol Med. 2016. PMID: 26711722
-
The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.Int J Clin Oncol. 2011 Dec;16(6):646-53. doi: 10.1007/s10147-011-0236-0. Epub 2011 Apr 29. Int J Clin Oncol. 2011. PMID: 21528380
-
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).Ann Oncol. 2008 Oct;19(10):1681-90. doi: 10.1093/annonc/mdn372. Epub 2008 Jun 16. Ann Oncol. 2008. PMID: 18558666 Review.
-
The role of human papillomavirus in oral squamous cell carcinoma (review).Georgian Med News. 2012 Dec;(213):32-6. Georgian Med News. 2012. PMID: 23293230 Review.
Cited by
-
The role of the epithelial sentinels, Langerhans cells and γδT cells, in oral squamous cell carcinoma.Periodontol 2000. 2024 Oct;96(1):221-228. doi: 10.1111/prd.12544. Epub 2024 Jan 25. Periodontol 2000. 2024. PMID: 38273461 Free PMC article. Review.
-
HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.Cancers (Basel). 2020 Apr 25;12(5):1060. doi: 10.3390/cancers12051060. Cancers (Basel). 2020. PMID: 32344813 Free PMC article. Review.
-
Prevalence of oral and oropharyngeal human papillomavirus infection in Brazilian population studies: a systematic review.Braz J Otorhinolaryngol. 2015 Sep-Oct;81(5):554-67. doi: 10.1016/j.bjorl.2015.04.001. Epub 2015 Jul 21. Braz J Otorhinolaryngol. 2015. PMID: 26248966 Free PMC article.
-
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites.Curr Oncol Rep. 2020 Jun 29;22(8):81. doi: 10.1007/s11912-020-00938-3. Curr Oncol Rep. 2020. PMID: 32602047 Free PMC article. Review.
-
Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.Cells. 2019 Sep 10;8(9):1061. doi: 10.3390/cells8091061. Cells. 2019. PMID: 31510065 Free PMC article.
References
-
- Anaya-Saavedra G, Ramirez-Amador V, Irigoyen-Camacho ME, García-Cuellar CM, Guido-Jiménez M, Méndez-Martínez R, et al. High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res. 2008;39:189–197. - PubMed
-
- Arany I, Tyring SK. Status of local cellular immunity in interferon-responsive and nonresponsive human papillomavirus associated lesions. Sex Transm Dis. 1998;23:475–480. - PubMed
-
- Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol. 2000;13:644–653. - PubMed
-
- Boy S, Van Rensburg EJ, Engelbrecht S, Dreyer L, Van Heerden M, Van Heerden W. HPV detection in primary intra-oral squamous cell carcinomas - commensal, aetiological agent or contamination? J Oral Pathol Med. 2006;35:86–90. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical